These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 12705785

  • 1. Antibodies to GM2 ganglioside in neurological disorders.
    Odaka M, Yuki N.
    Intern Med; 2003 Mar; 42(3):220-1. PubMed ID: 12705785
    [No Abstract] [Full Text] [Related]

  • 2. Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2.
    Mizutani K, Oka N, Kusunoki S, Kaji R, Kanda M, Akiguchi I, Shibasaki H.
    Intern Med; 2003 Mar; 42(3):277-80. PubMed ID: 12705795
    [Abstract] [Full Text] [Related]

  • 3. Peripheral neuropathy associated with anti-GM2 ganglioside antibodies: clinical and immunopathological studies.
    O'Hanlon GM, Veitch J, Gallardo E, Illa I, Chancellor AM, Willison HJ.
    Autoimmunity; 2000 Sep; 32(2):133-44. PubMed ID: 11078160
    [Abstract] [Full Text] [Related]

  • 4. Anti-ganglioside antibodies in patients with Guillain Barré syndrome and other neurological disorders.
    Vaishnavi C, Behura C, Prabhakar S, Sharma A, Kharbanda P.
    Indian J Med Microbiol; 2013 Sep; 31(2):177-9. PubMed ID: 23867676
    [Abstract] [Full Text] [Related]

  • 5. Novel lacto-ganglio type gangliosides with GM2-epitope in bovine brain which react with IgM from a patient of the amyotrophic lateral sclerosis-like disorder.
    Nakao T, Kon K, Ando S, Miyatake T, Yuki N, Li YT, Furuya S, Hirabayashi Y.
    J Biol Chem; 1993 Oct 05; 268(28):21028-34. PubMed ID: 7691804
    [Abstract] [Full Text] [Related]

  • 6. Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome.
    Ang CW, Jacobs BC, Brandenburg AH, Laman JD, van der Meché FG, Osterhaus AD, van Doorn PA.
    Neurology; 2000 Apr 11; 54(7):1453-8. PubMed ID: 10751257
    [Abstract] [Full Text] [Related]

  • 7. Guillain-Barré Syndrome in a Teenage Girl: A Severe Case With Anti-GM2 Antibodies Associated With Acute CMV Infection and Literature Review.
    Silva CT, Silva S, Silva MJ, Almeida AF, Fonseca J, Melo C, Sampaio M, Sousa R.
    Clin Pediatr (Phila); 2020 Mar 11; 59(3):300-304. PubMed ID: 31888351
    [No Abstract] [Full Text] [Related]

  • 8. Anti-GM2 antibody positive Guillain-Barré syndrome presenting with ataxia in a pediatric patient: An atypical manifestation.
    Deliceo Göbüt E, Us Ö, Işık U.
    Brain Dev; 2021 Jun 11; 43(6):729-733. PubMed ID: 33726944
    [Abstract] [Full Text] [Related]

  • 9. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection.
    Khalili-Shirazi A, Gregson N, Gray I, Rees J, Winer J, Hughes R.
    J Neurol Neurosurg Psychiatry; 1999 Mar 11; 66(3):376-9. PubMed ID: 10084538
    [Abstract] [Full Text] [Related]

  • 10. Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection.
    Cronin S, McNicholas R, Kavanagh E, Reid V, O'Rourke K.
    Ir J Med Sci; 2011 Mar 11; 180(1):255-7. PubMed ID: 21063804
    [Abstract] [Full Text] [Related]

  • 11. Anti-GM2, -GD1a and -GD1b positive purely isolated facial diplegia.
    Vachalová I, Golden V, Heckmann JG.
    Clin Neurol Neurosurg; 2014 Jul 11; 122():131-2. PubMed ID: 24813327
    [No Abstract] [Full Text] [Related]

  • 12. Detection of serum anti-ganglioside antibodies by latex agglutination assay in Guillain-Barré syndrome: comparison with ELISA.
    Irie S, Saito T, Kanazawa N, Ogino M, Ogino Y, Sakai F.
    Intern Med; 2003 Jun 11; 42(6):490-5. PubMed ID: 12857046
    [Abstract] [Full Text] [Related]

  • 13. Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome.
    Andersen SM, Ling CC, Zhang P, Townson K, Willison HJ, Bundle DR.
    Org Biomol Chem; 2004 Apr 21; 2(8):1199-212. PubMed ID: 15064799
    [Abstract] [Full Text] [Related]

  • 14. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome.
    Jacobs BC, van Doorn PA, Groeneveld JH, Tio-Gillen AP, van der Meché FG.
    J Neurol Neurosurg Psychiatry; 1997 Jun 21; 62(6):641-3. PubMed ID: 9219756
    [Abstract] [Full Text] [Related]

  • 15. Guillain-Barré syndrome following hepatitis E.
    Loly JP, Rikir E, Seivert M, Legros E, Defrance P, Belaiche J, Moonen G, Delwaide J.
    World J Gastroenterol; 2009 Apr 07; 15(13):1645-7. PubMed ID: 19340910
    [Abstract] [Full Text] [Related]

  • 16. Antiglycolipid antibodies in Guillain-Barré syndrome and autoimmune neuropathies.
    Kusunoki S.
    Am J Med Sci; 2000 Apr 07; 319(4):234-9. PubMed ID: 10768608
    [No Abstract] [Full Text] [Related]

  • 17. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C, Vial C, Petiot P, Bancel J, Later R, Gonnaud PM.
    Ann Biol Clin (Paris); 1999 Apr 07; 57(5):579-88. PubMed ID: 10518060
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Haemophilus influenzae infection and Guillain-Barré syndrome.
    Mori M, Kuwabara S, Miyake M, Noda M, Kuroki H, Kanno H, Ogawara K, Hattori T.
    Brain; 2000 Oct 07; 123 ( Pt 10)():2171-8. PubMed ID: 11004133
    [Abstract] [Full Text] [Related]

  • 20. Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research.
    Kusunoki S, Kaida K, Ueda M.
    Biochim Biophys Acta; 2008 Mar 07; 1780(3):441-4. PubMed ID: 17976386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.